Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease Progression
NCT06866236
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
NOT_YET_RECRUITING
Status
3000
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Kidney Diseases
Acute Kidney Injury
Kidney Failure
Interventions
DRUG:
QRX-3
Sponsor
Ebima Clifford Okundaye